57 related articles for article (PubMed ID: 28681401)
21. Brain morphological and microstructural features in cryptogenic late-onset temporal lobe epilepsy: a structural and diffusion MRI study.
Sone D; Sato N; Kimura Y; Watanabe Y; Okazaki M; Matsuda H
Neuroradiology; 2018 Jun; 60(6):635-641. PubMed ID: 29654334
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a Subtype of Autoimmune Encephalitis With Anti-Contactin-Associated Protein-like 2 Antibodies in the Cerebrospinal Fluid, Prominent Limbic Symptoms, and Seizures.
Joubert B; Saint-Martin M; Noraz N; Picard G; Rogemond V; Ducray F; Desestret V; Psimaras D; Delattre JY; Antoine JC; Honnorat J
JAMA Neurol; 2016 Sep; 73(9):1115-24. PubMed ID: 27428927
[TBL] [Abstract][Full Text] [Related]
23. Clinical Character of CASPR2 Autoimmune Encephalitis: A Multiple Center Retrospective Study.
Qin X; Yang H; Zhu F; Wang Q; Shan W
Front Immunol; 2021; 12():652864. PubMed ID: 34054814
[TBL] [Abstract][Full Text] [Related]
24. The prevalence of neural antibodies in temporal lobe epilepsy and the clinical characteristics of seropositive patients.
Elisak M; Krysl D; Hanzalova J; Volna K; Bien CG; Leypoldt F; Marusic P
Seizure; 2018 Dec; 63():1-6. PubMed ID: 30391660
[TBL] [Abstract][Full Text] [Related]
25. Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome.
Bien CG; Mirzadjanova Z; Baumgartner C; Onugoren MD; Grunwald T; Holtkamp M; Isenmann S; Kermer P; Melzer N; Naumann M; Riepe M; Schäbitz WR; von Oertzen TJ; von Podewils F; Rauschka H; May TW
Eur J Neurol; 2017 Jan; 24(1):175-186. PubMed ID: 27786401
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic challenges in patients with temporal lobe seizures and features of autoimmune limbic encephalitis.
Ismail FS; Spatola M; Woermann FG; Popkirov S; Jungilligens J; Bien CG; Wellmer J; Schlegel U
Eur J Neurol; 2022 May; 29(5):1303-1310. PubMed ID: 34288284
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and outcome of late-onset seizures due to autoimmune etiology: A prospective observational population-based cohort study.
von Podewils F; Suesse M; Geithner J; Gaida B; Wang ZI; Lange J; Dressel A; Grothe M; Kessler C; Langner S; Runge U; Bien CG
Epilepsia; 2017 Sep; 58(9):1542-1550. PubMed ID: 28681401
[TBL] [Abstract][Full Text] [Related]
28. Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature.
Joubert B; Kerschen P; Zekeridou A; Desestret V; Rogemond V; Chaffois MO; Ducray F; Larrue V; Daubail B; Idbaih A; Psimaras D; Antoine JC; Delattre JY; Honnorat J
JAMA Neurol; 2015 Oct; 72(10):1163-9. PubMed ID: 26280228
[TBL] [Abstract][Full Text] [Related]
29. [Limbic encephalitis: the new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications].
Dalmau J; Bataller L
Neurologia; 2007 Oct; 22(8):526-37. PubMed ID: 18000762
[TBL] [Abstract][Full Text] [Related]
30. Autoimmune Epilepsy.
Toledano M; Pittock SJ
Semin Neurol; 2015 Jun; 35(3):245-58. PubMed ID: 26060904
[TBL] [Abstract][Full Text] [Related]
31. Anti-contactin-associated protein-like 2 antibody-associated cerebellar ataxia: A case report and literature review.
Wang J; Qiu Z; Li D; Dong H; Hao J; Liu Z
J Neuroimmunol; 2021 Apr; 353():577515. PubMed ID: 33640718
[TBL] [Abstract][Full Text] [Related]
32. [Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis].
Yamamoto T; Tsuji S
Brain Nerve; 2010 Aug; 62(8):838-51. PubMed ID: 20714032
[TBL] [Abstract][Full Text] [Related]
33. Pathophysiology and Clinical Management of Autoimmune Encephalitis-Associated Seizures.
Zhu S; Yu J; Wu Y; Peng J; Xie X; Zhang X; Xie H; Sui L
Neuroimmunomodulation; 2022; 29(4):282-295. PubMed ID: 35580556
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
